bioRxivBiophysicsPreprint
Crystal structure of a mammalian CMTM6 and its interaction model with PD-L1
Abstract
CKLF-like MARVEL transmembrane domain-containing protein 6 (CMTM6) is a master regulator of PD-L1. By binding PD-L1 at the plasma membrane and recycling endosomes, CMTM6 prevents the lysosomal degradation of PD-L1 and maintains its cell surface expression, thus stabilizing the inhibitory PD-1/PD-L1 axis. However, the mechanism of CMTM6/PD-L1 interaction is unknown. Here we report the first experimentally determined structure of CMTM6 from bovine. Combined with a low-resolution cryo-EM map, computational docking analysis and a protein binding assay an interaction model between CMTM6 and PD-L1 was proposed, providing a structural framework for the CMTM6 regulation on PD-L1.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CMTM6 suppresses cell-surface expression of death receptor FAS in mice but not in humans
Tereza Šemberová, Michaela Přibíková, … Peter Dráber·EMBO ReportsPeer-reviewed·Feb 3, 2026
- Suppression of tumor/host intrinsic CMTM6 drives anti-tumor cytotoxicity in a PD-L1 independent manner
- Palmitoylation of PD-L1 Regulates Its Membrane Orientation and Immune Evasion
S. Zhang, H.-Y. Wang, … X. Lin·bioRxiv·Oct 17, 2021
- TRAF6 modulates PD-L1 expression through YAP1-TFCP2 signaling in melanoma
- The CD58:CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity
P. Ho, J. C. Melms, … B. Izar·bioRxiv·Mar 21, 2022
- CMTM6 maintains B cell intrinsic CD40 expression to regulate anti-tumor immunity